Neurocrine Biosciences (NBIX)

Add to Watchlists
Create an Alert
13.45 -0.39  -2.82% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
NBIX Price Chart
View All Events

NBIX Events

Date Type Description
Feb 06 Misc Neurocrine Biosciences, Inc. 4Q2013 Earning Conference Call
Feb 06 Earnings Neurocrine Biosciences, Inc. 4Q2013 Earning Result. Estimate: -0.17.
Oct 29 Misc Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2013 Financial Results Conference Call
Oct 29 Earnings Neurocrine Biosciences Reports Third Quarter 2013 Results. Estimate: -0.20.
Jul 25 Misc Q2 2013 Neurocrine Biosciences Earnings Conference Call
Jul 25 Earnings Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2013 Financial Results. Estimate: -0.20.
May 23 Misc AGM Event for Neurocrine Biosciences, Inc.
May 02 Misc Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results
May 02 Earnings Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results. Estimate: -0.17.
View All Performance Charts

NBIX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Neurocrine Biosciences is up 14.08% over the last year vs S&P 500 Total Return up 22.72%, Abbott Laboratories up 6.51%, and ImmunoBiotics down 92.14%.

Get Quote for

PDF Report for NBIX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NBIX Pro Report PDF
Advertisement

Portfolio Strategies Featuring NBIX

Did Neurocrine Biosciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NBIX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Neurocrine Biosciences, Inc., discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NBIX 13.45 -0.39 -2.82% 911.83M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.